Stock A358570 GI INNOVATION, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company GI Innovation, Inc.

Equities

A358570

KR7358570000

Biotechnology & Medical Research

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-07-14 pm EDT 		5-day change 1st Jan Change
12,460 KRW -1.03% Intraday chart for GI Innovation, Inc. +4.88% +3.40%
2023 GI Innovation, Inc.(KOSDAQ:A358570) added to S&P Global BMI Index CI
2023 GI Innovation, Inc. has completed an IPO in the amount of KRW 26 billion. CI

Business Summary

GI Innovation Inc is a Korea-based company engaged in the research and development of next-generation immunotherapies based on fusion proteins. The Company is engaged in the business of generating revenue through license fees by technology transfer of new drug candidates in pre-clinical and early clinical stages. The core new drug pipeline includes products such as GI-101 immuno-oncology and GI-301 allergy treatment.

Sales per Business

KRW in Million2022Weight2023Weight Delta
New Drug Development
100.0 %
3,500 100.0 % 5,319 100.0 % +51.97%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
100.0 %
3,500 100.0 % 5,319 100.0 % +51.97%

Managers

Managers TitleAgeSince
Jun-Ho Hong CEO
 Chief Executive Officer 52 21-06-15
Byeong-Geon Lee CEO
 Chief Executive Officer 67 22-03-03
Myung-Ho Jang PSD
 President 56 17-06-30
Young-Kyu Cho CTO
 Chief Tech/Sci/R&D Officer 55 19-08-31
Eun-Hee Rho IRC
 Investor Relations Contact 43 20-07-31
Eun-Sung Kim HRO
 Human Resources Officer 44 21-05-31

Members of the board

Members of the board TitleAgeSince
Byeong-Geon Lee CEO
 Chief Executive Officer 67 22-03-03
Geun-Yong An BRD
 Director/Board Member 49 22-03-02
Jun-Ho Hong CEO
 Chief Executive Officer 52 21-06-15
Myung-Ho Jang PSD
 President 56 17-06-30
Byung-Chul Kim BRD
 Director/Board Member 44 20-10-04
Hyun-Chul Kim BRD
 Director/Board Member 61 22-02-28
Yang-Ji Ryu BRD
 Director/Board Member 56 22-08-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 44,196,824 39,241,812 ( 88.79 %) 3,000 ( 0.006788 %) 88.79 %

Shareholders

NameEquities%Valuation
Myung-Ho Jang
6.912 %
3,054,806 6.912 % 23 M ₩
Dok-soo Jang
6.352 %
2,807,494 6.352 % 21 M ₩
Aju IB Investment Co., Ltd. (Private Equity)
5.323 %
2,352,484 5.323 % 18 M ₩
NH Investment & Securities Co., Ltd. /Private Equity/
4.375 %
1,933,700 4.375 % 15 M ₩
YUHAN CORPORATION
3.543 %
1,566,060 3.543 % 12 M ₩
Jae-hyun Kwon
3.394 %
1,500,082 3.394 % 11 M ₩
Su-Yeon Nam
2.795 %
1,235,122 2.795 % 9 M ₩
IMARKETKOREA INC.
2.743 %
1,212,120 2.743 % 9 M ₩
Kclavis Investment Co. Ltd.
2.473 %
1,092,808 2.473 % 8 M ₩
Hye-sung Lim
2.130 %
941,558 2.130 % 7 M ₩

Holdings

NameEquities%Valuation
GI INNOVATION, INC.
0.01%
 6,000 0.01% 45,245 $

Company contact information

GI Innovation, Inc.

167 Songpa-daero Songpa-gu

05855, Seoul

+

http://www.gi-innovation.com
address GI Innovation, Inc.(A358570)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
GI INNOVATION, INC. Stock GI Innovation, Inc.
+3.40% 398M
MODERNA, INC. Stock Moderna, Inc.
+22.15% 46.56B
LONZA GROUP AG Stock Lonza Group AG
+45.94% 41.67B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-2.37% 41.16B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
+33.84% 32.4B
CELLTRION, INC. Stock Celltrion, Inc.
-6.35% 28.1B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+20.42% 28.18B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+48.83% 14.52B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+45.00% 13.74B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+0.06% 12.17B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. A358570 Stock
  4. Company GI Innovation, Inc.